Sep 30, 2024
Project @ IfH: Culture-independent quantification of bacterial multiple drug resistance and resistance mobility
Towards next-generation AMR surveillance: Assessment of novel technologies with high-throughput and multiplexing potential
Various genetic and culture-based approaches are used for the surveillance of antimicrobial resistance (AMR). However, there are few harmonized, high-throughput platforms that target clinically relevant markers that indicate AMR mobility and multidrug resistance (MDR). In the TEXAS project, we will develop and validate two promising technological platforms addressing this gap. These technologies can be readily incorporated into national and international integrated surveillance programs.
Contact:
Dr. Magali de la Cruz Barron, Dr. David Kneis